ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0115

Improving Osteoporosis Screening in Men at a Resident-run Primary Care Clinic: A Quality Improvement Project

Khiem Vu1, Chima Ohadugha1, Kevin Dao1, Rabih Nayfe2 and Andrew Mangano1, 1Grand Strand Medical Center, Myrtle Beach, SC, 2Carolina Health Specialists - Rheumatology, Myrtle Beach, SC

Meeting: ACR Convergence 2020

Keywords: Bone density, Clinical Osteoporosis, Dual energy x-ray absorptiometry (DEXA), osteoporosis, practice guidelines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Osteoporosis & Metabolic Bone Disease Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: There are known indications for osteoporosis screening in women. However, osteoporosis also occurs in men and fragility fractures are linked to increased morbidity and mortality. Organizations as the National Osteoporosis Foundation, International Society for Clinical Densitometry, Endocrine Society, American College of Preventive Medicine, American College of Physicians, and American College of Rheumatology recommend that men ≥ 70 years old need universal screening for osteoporosis by dual energy x-ray absorptiometry. However, we have observed this recommendation to be underutilized in our resident clinic. The aim of this quality improvement project was to increase the documentation of osteoporosis screening in males ≥70 years old in our resident clinic (Grand Strand Primary Care) from the baseline 4-month average of 0% to ≥10% during the time period November 2019-May 2020.

Methods: Internal medicine residents were sent an educational email about osteoporosis screening in men ≥70 years old on November 1, 2019. It included the indications for screening in men, specific test to order, suggested diagnosis codes, references from literature, and solicited feedback regarding concerns about the project or clarification. Also, males ≥ 70 years old who were seen in clinic between July 1 and November 1, 2019 had their clinic notes reviewed for whether plans for screening was documented in the chart. Each resident was provided a customized list of patients (who had at least one scheduled follow-up in the next six months) for whom documentation about screening was lacking. Lastly, paper flyers were displayed in the clinic workspace similarly to those of other preventative health/screening recommendations for other medical conditions. On May 1, 2020 (six months later), charts were reviewed to evaluate the documentation rate of osteoporosis screening during the period November 1, 2019-May 1, 2020.

Results: Between July 1 and November 1, 2019, a total of 62 males ≥70 years old were seen in clinic among 26 residents. None of these patients had initial documentation regarding osteoporosis screening. Six months after our interventions (i.e. email sent on November 1, 2020, paper flyers displayed in clinic workroom), results were as follows: 11 patients were lost to follow-up (including one death), and 51 patients were seen at least once but osteoporosis screening was still not documented/discussed.

Conclusion: Our project did not meet the goal screening rate of at least 10% at six months. The results were humbling in that despite osteoporosis screening being recommended in men ≥70 years old by several medical organizations, screening rates remain exceptionally low, if not utilized at all. Although it is difficult to extrapolate our results to a broader scale, the major obstacles to screening most likely are limited life expectancy, prioritization of patients’ other comorbidities, cost (i.e. lack of insurance coverage), or the perception that osteoporosis is a disease solely of women. Further discussion must be held to reevaluate whether this universal screening recommendation will still hold in the future, or whether it is rather a highly individualized decision best discussed between patient and physician.


Disclosure: K. Vu, None; C. Ohadugha, None; K. Dao, None; R. Nayfe, None; A. Mangano, None.

To cite this abstract in AMA style:

Vu K, Ohadugha C, Dao K, Nayfe R, Mangano A. Improving Osteoporosis Screening in Men at a Resident-run Primary Care Clinic: A Quality Improvement Project [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/improving-osteoporosis-screening-in-men-at-a-resident-run-primary-care-clinic-a-quality-improvement-project/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-osteoporosis-screening-in-men-at-a-resident-run-primary-care-clinic-a-quality-improvement-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology